BIOASTER is the only health-related Technology Research Institut (TRI) in France selected by the General Commission for Investments [Commissariat Général à l'Investissement] as part of its Investments fot the Future [Programme des Investissements d'Avenir] program.
BIOASTER was established as a Foundation for Scientific Cooperation(FSC) based on an innovative public/private partnership model. It offers a novel approach to R&D based on integrating several scientific and technological disciplines.
BIOASTER conducts independent and collaborative interdisciplinary R&D activities on the frontier between basic and industrial development to ensure optimal alignment between research and innovation in the fields of infection diseases and microbiology and expand our understanding of intestinal microbiota and its impact on health.
BIOSPECIMENS has been developed to address the following concerns:
General issues raised by the scientific community:
• Access to biological resources held by biobanks is essential for industrial and academic scientists in order to translate basic research into development of treatments or new tools for diagnosis (Biobanks need pharma, Nature. 2009).
• Existing biological samples and their associated data suffer from a lack of visibility diagnosis.
...... and a strong demand from biotech companies and the academic and industrial sectors.
In 2011-2012, a working group focused on biological collections brought together BIOASTER’s founding members and partners (industrial companies, public research organizations, SMEs) to assess the scientific community’s needs and to provide recommendations on the missions of the future “Biological collections and Microbiology” technology unit.
It was concluded that its main task was to facilitate the identification and access to the biological resources needed for the research programs. These programs may regroup biological resource centers, hospital facilities and private or public research organizations.
BIOSPECIMENS answers sample requests from anyone studying microbiota or infectious disease, including clinicians, in-house BIOASTER researchers, outside academic or industrial partners, researchers from non-profit organizations, the national and international scientific community.
A first request can be made without a Bioaspecimens’ user account. This one will be created afterwards.
Any valid application in infectious disease and/or microbiology-related field will be reviewed in order to be included in a scientific collaboration with BIOASTER, or the be treated as an individual request.
BIOASTER is organized into cutting-edge technology units in the following domains:
If you are looking for an academic or an industrial partner or if you want to add a new technological dimension to your project, a BIOSPECIMENS administrator will discuss with you the opportunity to develop a collaborative research program in accordance with the BIOASTER strategy.
You can sign up for a free BIOSPECIMENS account to submit your sample request. A BIOSPECIMENS Administrator will contact you to review the criteria of your application and discuss the opportunity of setting up a collaboration with BIOASTER. Once your application has been validated and your biological samples identified through our network, a free estimate will be sent to you including:
• The BIOASTER fees associated with biological collections, which reflect the infrastructure required to match samples with your request and to procure, process, and ship the samples. (Sample identification, request administration, contractualization, enrichment in clinical data).
• The fees of our partner, which are related to the collection, the preparation and the storage of the samples.
BIOSPECIMENS will process your application the same way whether it is conducted as part of a collaborative project (Quote will be charged to the estimated budget for sample access) or a service delivery.
Relying on a unique network, BIOSPECIMENS develops customized protocols based on your needs:
• 819 Bacterial and 12 viral strains, which are listed on our website.
• Human samples (blood / serum / plasma, feces, urine) from healthy patients and a number of infectious diseases listed in the menu of our application form (HIV, hepatitis B, tuberculosis, hepatitis C, HPV, CMV, Measles, Whooping cough, Sepsis ...).
Our technology unit develops collaborations with key academic and industrial scientists in health and research. Any institution or any person wishing to share information on biological collections available for a research project can get in touch with our team.
Please complete the form "Communicate about your Collections" and describe the nature of the biological samples (and the diseases related to) which are available for a scientific research project. Our team will then contact you to obtain more information and to discuss the possibility of future collaboration.
No, the technology unit is not intended to manage biological samples conservation and session activities.
Our mission is to facilitate new collaborations around biological samples held by our partners and to optimize their scientific value. BIOASTER facilitates biological transfer from current biological holding centers to project leaders.